JY
IMCR icon

Jeff Yass’s Immunocore IMCR Stock Holding History

Jeff Yass’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07M Buy
65,200
+39,700
+156% +$1.17M ﹤0.01% 6406
2026
Q1 		$769K Buy
25,500
+500
+2% +$16.2K ﹤0.01% 8579
2025
Q4 		$868K Sell
25,000
-73,000
-74% -$2.58M ﹤0.01% 7502
2025
Q3 		$3.56M Sell
98,000
-400
-0.4% -$13.6K ﹤0.01% 4661
2025
Q2 		$3.09M Sell
98,400
-21,000
-18% -$652K ﹤0.01% 4903
2025
Q1 		$3.54M Buy
119,400
+111,800
+1,471% +$3.35M ﹤0.01% 4323
2024
Q4 		$224K Sell
7,600
-62,200
-89% -$1.97M ﹤0.01% 10466
2024
Q3 		$2.17M Sell
69,800
-22,000
-24% -$800K ﹤0.01% 5106
2024
Q2 		$3.11M Sell
91,800
-119,600
-57% -$6.1M ﹤0.01% 4237
2024
Q1 		$13.7M Buy
211,400
+21,100
+11% +$1.45M ﹤0.01% 2204
2023
Q4 		$13M Buy
190,300
+76,500
+67% +$3.98M ﹤0.01% 2307
2023
Q3 		$5.91M Sell
113,800
-75,600
-40% -$4.47M ﹤0.01% 3265
2023
Q2 		$11.4M Buy
189,400
+7,600
+4% +$434K ﹤0.01% 2353
2023
Q1 		$8.99M Buy
181,800
+95,800
+111% +$5.39M ﹤0.01% 2599
2022
Q4 		$4.91M Buy
86,000
+62,400
+264% +$3.51M ﹤0.01% 3268
2022
Q3 		$1.11M Sell
23,600
-9,700
-29% -$462K ﹤0.01% 6371
2022
Q2 		$1.24M Buy
+33,300
New +$1.08M ﹤0.01% 5989

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jeff Yass's IMCR Position: Q2 2026 in Review

Jeff Yass increased its Immunocore (IMCR) stake by 296% in Q2 2026, buying an estimated $756K and bringing the position to 34,170 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #7995.

Jeff Yass first reported a position in IMCR in Q2 2022 and has held it in 11 quarters since. The position peaked at $3.49M in Q3 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Jeff Yass held 34,170 shares of Immunocore worth $1.08M as of Q2 2026.
  • Jeff Yass bought 25,548 Immunocore shares in Q2 2026, an estimated $756K.
  • Immunocore made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7995 holding.
  • Jeff Yass first reported a position in Immunocore in Q2 2022 and has held it in 11 quarters since.
  • Jeff Yass's Immunocore position peaked at $3.49M in Q3 2024.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.